nodes	percent_of_prediction	percent_of_DWPC	metapath
Pasireotide—SSTR1—midbrain—nicotine dependence	0.0311	0.338	CbGeAlD
Pasireotide—SSTR3—brain—nicotine dependence	0.0247	0.269	CbGeAlD
Pasireotide—SSTR3—Peptide GPCRs—OPRM1—nicotine dependence	0.0241	0.0331	CbGpPWpGaD
Pasireotide—SSTR1—Peptide GPCRs—OPRM1—nicotine dependence	0.0231	0.0317	CbGpPWpGaD
Pasireotide—SSTR3—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.0227	0.0311	CbGpPWpGaD
Pasireotide—SSTR1—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.0218	0.0299	CbGpPWpGaD
Pasireotide—SSTR5—Peptide GPCRs—OPRM1—nicotine dependence	0.0205	0.0281	CbGpPWpGaD
Pasireotide—SSTR1—brain—nicotine dependence	0.0196	0.212	CbGeAlD
Pasireotide—SSTR5—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.0193	0.0265	CbGpPWpGaD
Pasireotide—SSTR2—Peptide GPCRs—OPRM1—nicotine dependence	0.0189	0.026	CbGpPWpGaD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.0187	0.0256	CbGpPWpGaD
Pasireotide—SSTR2—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.0178	0.0244	CbGpPWpGaD
Pasireotide—SSTR2—brain—nicotine dependence	0.0166	0.181	CbGeAlD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.0153	0.021	CbGpPWpGaD
Pasireotide—SSTR3—GPCR ligand binding—TAS2R16—nicotine dependence	0.0137	0.0189	CbGpPWpGaD
Pasireotide—SSTR1—GPCR ligand binding—TAS2R16—nicotine dependence	0.0132	0.0181	CbGpPWpGaD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.0125	0.0171	CbGpPWpGaD
Pasireotide—Diabetes mellitus—Varenicline—nicotine dependence	0.0117	0.0655	CcSEcCtD
Pasireotide—SSTR5—GPCR ligand binding—TAS2R16—nicotine dependence	0.0117	0.016	CbGpPWpGaD
Pasireotide—SSTR3—Peptide ligand-binding receptors—OPRM1—nicotine dependence	0.0113	0.0156	CbGpPWpGaD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.0113	0.0155	CbGpPWpGaD
Pasireotide—SSTR1—Peptide ligand-binding receptors—OPRM1—nicotine dependence	0.0109	0.0149	CbGpPWpGaD
Pasireotide—SSTR2—GPCR ligand binding—TAS2R16—nicotine dependence	0.0108	0.0148	CbGpPWpGaD
Pasireotide—Hypoglycaemia—Varenicline—nicotine dependence	0.0104	0.0583	CcSEcCtD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.0102	0.014	CbGpPWpGaD
Pasireotide—SSTR5—Peptide ligand-binding receptors—OPRM1—nicotine dependence	0.00965	0.0132	CbGpPWpGaD
Pasireotide—SSTR3—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00957	0.0131	CbGpPWpGaD
Pasireotide—Dry skin—Varenicline—nicotine dependence	0.00933	0.0522	CcSEcCtD
Pasireotide—Abdominal pain upper—Varenicline—nicotine dependence	0.00929	0.052	CcSEcCtD
Pasireotide—Hypokalaemia—Varenicline—nicotine dependence	0.00926	0.0518	CcSEcCtD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00926	0.0127	CbGpPWpGaD
Pasireotide—SSTR1—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00918	0.0126	CbGpPWpGaD
Pasireotide—Nasopharyngitis—Varenicline—nicotine dependence	0.0091	0.0509	CcSEcCtD
Pasireotide—SSTR2—Peptide ligand-binding receptors—OPRM1—nicotine dependence	0.0089	0.0122	CbGpPWpGaD
Pasireotide—SSTR3—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00888	0.0122	CbGpPWpGaD
Pasireotide—Abdominal distension—Varenicline—nicotine dependence	0.00885	0.0495	CcSEcCtD
Pasireotide—SSTR1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00852	0.0117	CbGpPWpGaD
Pasireotide—SSTR5—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00814	0.0112	CbGpPWpGaD
Pasireotide—Hyperglycaemia—Varenicline—nicotine dependence	0.00793	0.0444	CcSEcCtD
Pasireotide—SSTR3—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00777	0.0107	CbGpPWpGaD
Pasireotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00761	0.0104	CbGpPWpGaD
Pasireotide—SSTR5—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00755	0.0104	CbGpPWpGaD
Pasireotide—SSTR2—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00751	0.0103	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00745	0.0102	CbGpPWpGaD
Pasireotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.0073	0.01	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—TAS2R16—nicotine dependence	0.00706	0.00968	CbGpPWpGaD
Pasireotide—SSTR2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00697	0.00956	CbGpPWpGaD
Pasireotide—Oedema peripheral—Varenicline—nicotine dependence	0.00693	0.0388	CcSEcCtD
Pasireotide—SSTR3—G alpha (i) signalling events—DRD2—nicotine dependence	0.00692	0.00949	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—TAS2R16—nicotine dependence	0.00676	0.00928	CbGpPWpGaD
Pasireotide—SSTR1—G alpha (i) signalling events—DRD2—nicotine dependence	0.00663	0.0091	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00661	0.00906	CbGpPWpGaD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00647	0.00887	CbGpPWpGaD
Pasireotide—SSTR3—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00642	0.00881	CbGpPWpGaD
Pasireotide—SSTR1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00616	0.00844	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—FGD1—nicotine dependence	0.0061	0.00836	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.0061	0.00836	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—TAS2R16—nicotine dependence	0.006	0.00823	CbGpPWpGaD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00597	0.00819	CbGpPWpGaD
Pasireotide—Back pain—Varenicline—nicotine dependence	0.00593	0.0332	CcSEcCtD
Pasireotide—SSTR5—G alpha (i) signalling events—DRD2—nicotine dependence	0.00588	0.00807	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—FGD1—nicotine dependence	0.00584	0.00802	CbGpPWpGaD
Pasireotide—SSTR3—GPCR ligand binding—OPRM1—nicotine dependence	0.0058	0.00795	CbGpPWpGaD
Pasireotide—Anaemia—Varenicline—nicotine dependence	0.00566	0.0317	CcSEcCtD
Pasireotide—SSTR1—GPCR ligand binding—OPRM1—nicotine dependence	0.00556	0.00762	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—FGD1—nicotine dependence	0.00554	0.00759	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—TAS2R16—nicotine dependence	0.00554	0.00759	CbGpPWpGaD
Pasireotide—Vertigo—Varenicline—nicotine dependence	0.00551	0.0308	CcSEcCtD
Pasireotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.0055	0.00755	CbGpPWpGaD
Pasireotide—SSTR5—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00546	0.00749	CbGpPWpGaD
Pasireotide—SSTR2—G alpha (i) signalling events—DRD2—nicotine dependence	0.00543	0.00745	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—FGD1—nicotine dependence	0.00531	0.00728	CbGpPWpGaD
Pasireotide—Hypertension—Varenicline—nicotine dependence	0.00529	0.0296	CcSEcCtD
Pasireotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00528	0.00723	CbGpPWpGaD
Pasireotide—Arthralgia—Varenicline—nicotine dependence	0.00522	0.0292	CcSEcCtD
Pasireotide—Myalgia—Varenicline—nicotine dependence	0.00522	0.0292	CcSEcCtD
Pasireotide—Anxiety—Varenicline—nicotine dependence	0.0052	0.0291	CcSEcCtD
Pasireotide—SSTR5—GPCR downstream signaling—FGD1—nicotine dependence	0.00518	0.00711	CbGpPWpGaD
Pasireotide—SSTR2—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00504	0.00691	CbGpPWpGaD
Pasireotide—SSTR5—GPCR ligand binding—OPRM1—nicotine dependence	0.00493	0.00676	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—FGD1—nicotine dependence	0.00478	0.00656	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—FGD1—nicotine dependence	0.00471	0.00646	CbGpPWpGaD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00468	0.00642	CbGpPWpGaD
Pasireotide—Hypotension—Varenicline—nicotine dependence	0.00467	0.0261	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00456	0.0255	CcSEcCtD
Pasireotide—SSTR2—GPCR ligand binding—OPRM1—nicotine dependence	0.00455	0.00624	CbGpPWpGaD
Pasireotide—Insomnia—Varenicline—nicotine dependence	0.00452	0.0253	CcSEcCtD
Pasireotide—Decreased appetite—Varenicline—nicotine dependence	0.00435	0.0243	CcSEcCtD
Pasireotide—SSTR2—Signaling by GPCR—FGD1—nicotine dependence	0.00434	0.00596	CbGpPWpGaD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00432	0.00592	CbGpPWpGaD
Pasireotide—Fatigue—Varenicline—nicotine dependence	0.00431	0.0241	CcSEcCtD
Pasireotide—Constipation—Varenicline—nicotine dependence	0.00428	0.0239	CcSEcCtD
Pasireotide—SSTR3—GPCR ligand binding—DRD2—nicotine dependence	0.00419	0.00575	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—TAS2R16—nicotine dependence	0.00417	0.00572	CbGpPWpGaD
Pasireotide—Gastrointestinal pain—Varenicline—nicotine dependence	0.00409	0.0229	CcSEcCtD
Pasireotide—SSTR1—GPCR ligand binding—DRD2—nicotine dependence	0.00402	0.00551	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—TAS2R16—nicotine dependence	0.004	0.00548	CbGpPWpGaD
Pasireotide—Abdominal pain—Varenicline—nicotine dependence	0.00395	0.0221	CcSEcCtD
Pasireotide—Asthenia—Varenicline—nicotine dependence	0.00359	0.0201	CcSEcCtD
Pasireotide—SSTR5—GPCR ligand binding—DRD2—nicotine dependence	0.00356	0.00489	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—TAS2R16—nicotine dependence	0.00354	0.00486	CbGpPWpGaD
Pasireotide—Pruritus—Varenicline—nicotine dependence	0.00354	0.0198	CcSEcCtD
Pasireotide—Diarrhoea—Varenicline—nicotine dependence	0.00342	0.0191	CcSEcCtD
Pasireotide—Dizziness—Varenicline—nicotine dependence	0.00331	0.0185	CcSEcCtD
Pasireotide—SSTR2—GPCR ligand binding—DRD2—nicotine dependence	0.00329	0.00451	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—OPRM1—nicotine dependence	0.00328	0.00449	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—FGD1—nicotine dependence	0.00327	0.00449	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—TAS2R16—nicotine dependence	0.00327	0.00449	CbGpPWpGaD
Pasireotide—Vomiting—Varenicline—nicotine dependence	0.00318	0.0178	CcSEcCtD
Pasireotide—SSTR1—GPCR downstream signaling—OPRM1—nicotine dependence	0.00314	0.00431	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—FGD1—nicotine dependence	0.00314	0.0043	CbGpPWpGaD
Pasireotide—Headache—Varenicline—nicotine dependence	0.00313	0.0175	CcSEcCtD
Pasireotide—SSTR3—Signaling by GPCR—OPRM1—nicotine dependence	0.00297	0.00408	CbGpPWpGaD
Pasireotide—Nausea—Varenicline—nicotine dependence	0.00297	0.0166	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—AKR1B10—nicotine dependence	0.00289	0.00396	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—OPRM1—nicotine dependence	0.00285	0.00391	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—OPRM1—nicotine dependence	0.00278	0.00382	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—FGD1—nicotine dependence	0.00278	0.00381	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—AKR1B10—nicotine dependence	0.00277	0.0038	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—OPRM1—nicotine dependence	0.00257	0.00352	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—FGD1—nicotine dependence	0.00257	0.00352	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—OPRM1—nicotine dependence	0.00253	0.00347	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—AKR1B10—nicotine dependence	0.00246	0.00337	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—DRD2—nicotine dependence	0.00237	0.00325	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—OPRM1—nicotine dependence	0.00233	0.0032	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—DRD2—nicotine dependence	0.00227	0.00311	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—AKR1B10—nicotine dependence	0.00227	0.00311	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—DRD2—nicotine dependence	0.00215	0.00295	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—DRD2—nicotine dependence	0.00206	0.00283	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—WASF2—nicotine dependence	0.00204	0.00279	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—DRD2—nicotine dependence	0.00201	0.00276	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—WASF1—nicotine dependence	0.00195	0.00268	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—WASF2—nicotine dependence	0.00195	0.00268	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—WASF1—nicotine dependence	0.00187	0.00257	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—DRD2—nicotine dependence	0.00186	0.00255	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—DRD2—nicotine dependence	0.00183	0.00251	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—OPRM1—nicotine dependence	0.00176	0.00241	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—WASF2—nicotine dependence	0.00173	0.00237	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—DRD2—nicotine dependence	0.00169	0.00231	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—OPRM1—nicotine dependence	0.00168	0.00231	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—WASF1—nicotine dependence	0.00166	0.00228	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—WASF2—nicotine dependence	0.0016	0.00219	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—WASF1—nicotine dependence	0.00153	0.0021	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—OPRM1—nicotine dependence	0.00149	0.00205	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—OPRM1—nicotine dependence	0.00138	0.00189	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—DRD2—nicotine dependence	0.00127	0.00174	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—DRD2—nicotine dependence	0.00122	0.00167	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—DRD2—nicotine dependence	0.00108	0.00148	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—DRD2—nicotine dependence	0.000997	0.00137	CbGpPWpGaD
